Round table sessions with leading healthcare experts confirm the potential for a multidisciplinary care pathway for patients with type 2 inflammatory diseases
Round table sessions with leading healthcare experts confirm the potential for a multidisciplinary care pathway for patients with type 2 inflammatory diseases - Read the paper here.
More infoCall for a national Asthma plan – discover the survey outcomes
eureca shares the Asthma survey outcomes, in our pursuit of an adequate solution to the problems it reveals: a national asthma plan.
More infoOxypoint – a Eureca Pulmonary Innovation Company
OXYPOINT - The O2COMFORT flowmeter: a Belgian innovative solution to reduce oxygen waste and improve patient care in hospitals
More infoProceedings “Innovative formulation for inhaled drugs’ – now online
VITO and eu.reca vzw organized a webinar that was completely devoted to indoor air purification on June 1st. We have summarized the session in these proceedings.
More infoChiesi becomes a eu.reca Gold Sponsor
Chiesi is proud to continue the support of Eu.reca as Gold Partner. Through this partnership, Chiesi wants to improve the quality and treatment of patients with respiratory diseases, focussing on Asthma and COPD.
More infoALERT: Assessing heaLth Effects of aiR pollution by non-invasive exhaled breaTh analysis.
ALERT aims at mapping the air pollution in the Antwerp region and assessing the impact of air pollution exposure on health and respiratory functioning of healthy persons and persons susceptible for air pollution (COPD and asthma patients).
More info